Article Text

PDF
CASE REPORT
Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
  1. Beatrice Alexandra Golomb1,
  2. Hayley Jean Koslik1,
  3. Alan J Redd2
  1. 1Department of Medicine, University of California, San Diego, La Jolla, California, USA
  2. 2Department of Anthropology, University of Kansas, Lawrence, Kansas, USA
  1. Correspondence to Dr Beatrice Alexandra Golomb, bgolomb{at}ucsd.edu

Summary

We present a case series of four previously healthy, employed adults without significant prior medical history in each of whom symptoms developed while on fluoroquinolones (FQs), with progression that continued following discontinuation evolving to a severe, disabling multisymptom profile variably involving tendinopathy, muscle weakness, peripheral neuropathy, autonomic dysfunction, sleep disorder, cognitive dysfunction and psychiatric disturbance. Physicians and patients should be alert to the potential for FQ-induced severe disabling multisymptom pathology that may persist and progress following FQ use. Known induction by FQs of delayed mitochondrial toxicity provides a compatible mechanism, with symptom profiles (and documented mechanisms of FQ toxicity) compatible with the hypothesis of an exposure-induced mitochondrial neurogastrointestinal encephalomyopathy.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.